|
Group |
I |
II |
III |
IV |
Dose |
0 mg/kg |
750 mg/kg |
400 mg/kg |
750 + 400 mg/kg |
Uterus Weight (g) |
Mean |
55.06 |
47.36 |
52.70 |
54.62 |
SD |
17.12 |
16.61 |
7.51 |
17.26 |
n |
9 |
9 |
8 |
9 |
CL |
Mean |
10.22 |
8.56 |
11.75 |
10.33 |
SD |
2.64 |
2.88 |
1.16 |
2.6 |
n |
9 |
9 |
8 |
9 |
Implants |
Mean |
10.00 |
8.44 |
11.63 |
10.11 |
SD |
2.83 |
2.79 |
1.19 |
2.42 |
n |
9 |
9 |
8 |
9 |
Live Fetuses |
Mean |
9.89 |
8.11 |
10.38 |
9.78 |
SD |
2.8 |
2.85 |
1.6 |
3.27 |
n |
9 |
9 |
8 |
9 |
Dead Fetuses |
Mean |
0.00 |
0.00 |
0.00 |
0.00 |
SD |
0.0 |
0.0 |
0.0 |
0.0 |
n |
9 |
9 |
8 |
9 |
Early Resorptions |
Mean |
0.11 |
0.00 |
1.00 |
0.33 |
SD |
0.33 |
0.00 |
2.07 |
1.00 |
n |
9 |
9 |
8 |
9 |
Late resorption |
Mean |
0.11 |
0.33 |
0.38 |
0.00 |
SD |
0.33 |
0.5 |
0.52 |
0.0 |
n |
9 |
9 |
8 |
9 |
Group I: Control Group II: β Cyclodextrin, III: Tolbutamide IV: β Cyclodextrin + tolbutamide |